Stimdia Medical Inc. Initiates FDA Approved IDE Pivotal Trial to Investigate Impact of Neuromuscular Stimulation on Mechanically Ventilated Patients – link
October 2023 | News
Stimdia Medical Announces Close of Series B Equity Financing Round with Proceeds to be Used to Complete the Company’s Pivotal Study – link
July 2022 | News
Stimdia Medical receives FDA breakthrough device designation for the pdSTIM™ System designed to facilitate weaning patients from mechanical ventilation – link
March 2021 | News
Results of PEPNS study published in Critical Care Medicine, official journal of the Society of Critical Care Medicine (SCCM) – link
May 2020 | News
Results of PEPNS study presented during the European Society of Intensive Care Medicine’s (ESICM) 32nd Annual Congress held in Berlin, Germany – link
September 2019 | News
Stimdia Medical reports completion of enrollment and follow-up for PEPNS study
February 2019 | News
Stimdia Medical reports successful completion of 30 day follow-up on first two patients enrolled into landmark PEPNS study
October 2018 | News
Stimdia Medical completes GLP chronic study for PEPNS System
March 2018 | News
Stimdia Medical receives 2nd Tranche for Series A1 Financing
March 2018 | News
Stimdia Medical receives 1st Tranche for Series A1 Financing
December 2017 | News
Stimdia Medical completes GLP acute phase study for PEPNS System
December 2017 | News
Stimdia Medical granted landmark foundational patent associated with electrical stimulation for preservation and restoration of diaphragm function
June 2017 | News
Stimdia Medical completes Series A Option 2x Financing
March 2017 | News
Andarta Medical changes name to Stimdia Medical
March 2016 | News
Andarta Medical closes Series A funding with world class investor syndicate Draper Triangle Ventures (Mr. Jay Katarinic), the University of Minnesota Discovery Capital Program (Mr. Russ Straate) and Industry Veteran Executive and Investor James Bullock
December 2015 | News
